Cervical cancer incidence among women aged 15 to 34 in Korea has reached 5 per 100,000, ranking fourth after thyroid, breast, and colorectal cancer.
Many women in their 20s still assume cervical cancer screening is “for older women.”
But the cervical cancer screening age Korea has set already starts at 20 and up, and knowing exactly who qualifies can make a real difference in early detection.
This article walks through how the cervical cancer screening age Korea has expanded, who qualifies in 2026, the screening interval, free screening for women in their 20s, and how the program may change going forward.
Korea’s national program covers Pap smear screening from age 20 onward.

Cervical Cancer Screening Age Korea: How Has It Expanded?
Any woman aged 20 or older qualifies for Korea’s national cervical cancer screening.
National cervical cancer screening in Korea is a free Pap smear-based program offered every two years to women aged 20 and up.
The starting age used to be 30, but it was lowered to 20 in 2016, expanding the screening age significantly.
The National Health Insurance Service (NHIS, Korea’s public health insurance corporation) covers the full cost for insured members, their dependents, and Medical Aid beneficiaries (Korea’s coverage for low-income residents).
· Eligible age: women 20 and older
· Cost: fully covered by NHIS (free)
· Test used: Pap smear (cervical cytology)
Source: National Health Insurance Service (NHIS), “Prevent Cervical Cancer Early,” 2022.
How Often Should You Get a Cervical Cancer Screening in Korea?
If your last result was normal, once every two years is enough.
The screening interval is a two-year cycle: you’re called up in the year that matches your birth year’s odd/even parity.
In 2026 (an even year), women born in even years are eligible; in 2025, women born in odd years were.
If a past result showed abnormal cells or a positive HPV test, your doctor may shorten the interval to one year or even six months, so always check the follow-up date on your result.
✅ Are you 20 or older?
✅ Were you born in an even year (for 2026)?
✅ Are you an NHIS member, dependent, or Medical Aid beneficiary?
✅ Have you checked your status on the NHIS app (The건강보험)?
Source: National Health Insurance Service (NHIS), National Cancer Information Center.
Is Free Cervical Cancer Screening Available for Women in Their 20s?
Yes. Women in their 20s (20 and older) are fully covered under the national program.
Even so, screening rates among women in their 20s tend to lag behind older age groups.
Work schedules and reluctance to visit a gynecologist are common reasons, along with the misconception that no symptoms means no risk.
Given that cervical cancer already ranks 4th in incidence among women aged 15-34, this isn’t an age group that can afford to skip screening.
Since earlier HPV exposure raises risk, screening eligibility applies at 20 and up regardless of sexual history — worth remembering if you’ve been putting it off.
Screening matters even without symptoms. Talk to a gynecologist about whether screening makes sense for your individual situation.
Source: MedWorld News, “Cervical Cancer Ranks 4th in Incidence Among Women Aged 15-34,” March 5, 2025.
Will Korea’s National Cervical Cancer Screening Expand Further?
There’s active discussion about adding or shifting to HPV DNA testing alongside the current Pap smear-based program.
The WHO recommended HPV DNA testing as the primary screening method in 2021, and countries like Australia, EU member states, and the US have already adopted or expanded it.
Korea’s current Pap smear has a sensitivity of roughly 50-70%, compared to over 96% for HPV DNA testing — a gap medical societies in Korea have repeatedly cited when calling for the program to be updated.
Cervical cancer cases in Korea rose from 61,636 in 2020 to 70,598 in 2024, about 15%, while HPV infection cases jumped 32.8%, from 10,945 to 14,534, over the same period.
The WHO’s 90-70-90 elimination strategy — 90% of girls vaccinated by 15, 70% of women screened with a high-performance test by 35 and again by 45, and 90% of detected cases treated by 2030 — could shape how Korea’s own program evolves.
For related exam and procedure guides, see the category page. Exams & Procedures Guide (Internal link: to be replaced with a related article once published)
Source: Doctors News (의협신문), “Low Sensitivity in National Cervical Cancer Screening Sparks Calls for HPV DNA Testing” (자궁경부암 국가검진 민감도 낮아 “HPV DNA 검사 도입해야”), Sept. 19, 2025 / WHO, “Cervical Cancer” Fact Sheet.
Frequently Asked Questions
1. Is Korea’s national cervical cancer screening really free?
Yes. If you’re 20 or older and it’s your eligible year, the NHIS covers the full cost.
2. Am I eligible for screening in 2026?
2026 is an even year, so women born in even years are eligible. Check your exact status on the NHIS website or app.
3. Do I need screening even without sexual experience?
Eligibility applies to all women 20 and older regardless of sexual history. Talk with a gynecologist about your individual situation.
4. What happens if my results show something abnormal?
Your follow-up interval is usually shortened to one year or six months, and further testing (including HPV testing) may be recommended. Follow the guidance on your results notice.
5. If I got the HPV vaccine, can I skip screening?
No. The HPV vaccine doesn’t cover every high-risk strain, so regular screening is still recommended regardless of vaccination status.
References
1. National Health Insurance Service (NHIS), “Prevent Cervical Cancer Early,” 2022. Link
2. National Cancer Information Center (National Cancer Center Korea), “Cervical Cancer.” Link
3. Doctors News (의협신문), “Low Sensitivity in National Cervical Cancer Screening Sparks Calls for HPV DNA Testing,” Sept. 19, 2025. Link
4. MedWorld News, “Cervical Cancer Ranks 4th in Incidence Among Women Aged 15-34,” March 5, 2025. Link
5. WHO, “Cervical Cancer” Fact Sheet, 2025. Link
6. Mayo Clinic News Network, “Mayo Clinic Q and A: Cervical Cancer and HPV Screening.” Link
This article is for general informational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Please consult a qualified healthcare provider if you have health concerns.












